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Abstract
Objective
Becker Muscular Dystrophy (BMD) is a neuromuscular disorder 
which is incurable. In this research protein interaction network of 
most associated proteins with BMD to provide better clarification of 
disorder underlying mechanism was investigated. 
Materials & Methods
The related genes to BMD were retrieved via string database and 
conducted by Cytoscape and the related algorithms. The network 
centrality analysis was performed based on degree, betweenness, 
closeness, and stress parameters. Gene ontology and clustering were 
performed via ClueGO analysis. 
Results
DMD as the super-hub as well as other central proteins including 
UTRN, TTN, DNM2, and RYR1 are important in BMD in terms of 
interactive features. The impairment of muscular contraction may be 
vital in BMD disease pathogenesis as it is the highlighted biological 
process term obtained by ClueGO analysis.
Conclusion
DMD targeting may be the main concern for dystrophy clinical 
approaches. However, the other suggested proteins should be 
evaluated. Targeting these key proteins are required for treatment 
goals following extensive validation studies. 
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Introduction
Becker Muscular Dystrophy is a less severe type 
of dystrophy than Duchenne muscular dystrophy 
(1). This type of neuromuscular disorder is mainly 
known with dysfunctional protein dystrophin (2). 
As there is no therapy available for BMD, molecular 
examination can be helpful in this regard (3). 
The potential molecules contributing to disease 
pathogenesis can be targeted for treatments (4, 
5). Many investigations in this light have been 
conducted and provided further information about 
this disease and with possible usage in clinical 
goals (6). The analysis conducted up until today 
showed the contribution of many molecules for 
this disease that worth more evaluations (7, 8). 
However, due to the complex molecular nature 
of muscular dystrophy, more studies in terms of 
proteins as the functional level of cell is required 
(9). 
The way these proteins communicate can their 
linkage results in many different phenotypes are 
known as protein-protein interaction network 
(10). Any changes in this interaction unit may 
lead to phenotype alterations and sometimes 
the manifestation of a specific disease. This 
procedure is related to how the communication 
of these proteins can affect other proteins and 
the contributing pathways (11). Therefore, by 
analyzing these features the possible knowledge of 
molecular behavior of any kinds of diseases can be 
better understood (12). In addition, by examining 
proteins with prioritized topological features, 
potential nominates for biomarker discovery can 
be introduced. 
Moreover, more in-depth knowledge can be 
achieved through these studies by exploring the 
functional roles and biological processes related 
to these central proteins (13). On the other hand, 
expression changes in these types may result in 
vast dysregulation in the whole PPI network and 
accordingly, a disease phenotype may manifest 
(13).  Etiology of Becker muscular dystrophy can 
be better explained by protein-protein interaction 
(PPI) network analysis and wide validation methods 
applications. Here, an introductory network value 
of this important muscular disease is suggested. 
Materials & Methods
For the network construction, the used application 
was Cytoscape 3.4.0. (14). Through Cytoscape, 
STRING Database provided the essential 
information for interaction pattern by the use of 
different sources and combined confidence score 
(15). The setting for network construction was 
as follows: Number of nodes: 100 and combined 
confidence score cutoff= 0.5. However, only 93 
one among the 100 genes were included in the 
constructed network.
Following network construction, connectivity 
degree, betweenness, closeness, and stress as 
the key topological parameters were adopted to 
interfere the centrality properties of the constructed 
network. Nodes with high degree values are known 
as hub proteins. Hubs have many connections 
and any changes in them can result in extensive 
disruption of the whole interaction system. Tnode 
with high value of betweenness is called bottleneck 
node (16). For node evaluation, 10 top nodes based 
on the four mentioned centrality parameters have 
been selected. In this way, the central nodes of a 
network identify (17).
Further analysis was conducted based on gene 
ontology examinations. ClueGO + CluePedia 
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Cytoscape plug-ins explored the gene ontology 
(GO) annotations (18, 19). Controlled vocabulary 
of three biological annotations including cellular 
component, molecular function, and biological 
process terms are implemented by GO source (20). 
The statistical test for this analysis was Kappa score. 
High kappa score indicates the higher possibility 
that terms group together. The cut off for here was 
set 0.5. In addition, genes per term was considered 
3 and the percentage was set to 4. The minimum 
and maximum level of ontology were set to 3 to 
8 as the default option, respectively. The P-value 
was also set to ≤0.05 and Bonferroni step down 
as the correction method. Two-sided (enrichment/
depletion) based on hypergeometric test was also 
selected as the default option. 
Results
Protein network construction of Becker muscular 
dystrophy via String Database and Cytoscape is 
shown in Figure 1. 
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Figure 1. The network view of Becker muscular dystrophy analyzed by Cytoscape. Statistical 
properties of the network are shown in the down of the figure. Network consists of 93 nodes 
including 29 isolated nodes, one paired nodes and 62 organized nodes in the main connected 
component.  
Centrality analysis of the network was by the use of Network Analyzer. This algorithm is well 
established in Cytoscape and can provide essential topological parameters’ properties. Here, 
degree, betweenness, closeness, and stress as the most central characteristic of a PPI network are 
considered for centrality evaluation (Table 1). If a protein was hub or bottleneck and was 
included in the selected nodes based on closeness and stress was introduced as crucial proteins 
(Table 2). Gene ontology examination can be handled by the application of ClueGO. Here, the 
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Centrality analysis of the network was by the 
use of Network Analyzer. This algorithm is 
well established in Cytoscape and can provide 
essential topological parameters’ properties. Here, 
degree, betweenness, closeness, and stress as the 
most central characteristic of a PPI network are 
considered for centrality evaluation (Table 1). If a 
protein was hub or bottleneck and was included in 
the selected nodes based on closeness and stress 
was introduced as as a crucial protein proteins 
(Table 2). Gene ontology examination can be 
handled by the application of ClueGO. Here, the 
biological process evaluation of the main network 
was assessed (Figure 2).
Table 1. The 10 top nodes based on degree (D), betweenness (B), closeness (C) and stress (S) 
R Gene Name D Gene Name B Gene Name C Gene Name S
1 DMD 39 DMD 0.406106 GPR17 1 DMD 4516
2 UTRN 25 DNM2 0.187341 GRM3 1 DNM2 2232
3 SGCG 19 STAU1 0.12623 DMD 0.663043 UTRN 1890
4 CAV3 19 RYR1 0.103262 UTRN 0.544643 TRIM32 1670
5 TTN 19 UTRN 0.095463 TTN 0.530435 STAU1 1462
6 SGCA 17 TTN 0.074896 CAV3 0.488 MYOD1 1318
7 CAPN3 16 MYOD1 0.074827 DAG1 0.484127 RYR1 1200
8 DAG1 16 VCL 0.073312 DNM2 0.480315 MYOG 966
9 SNTA1 15 ILF2 0.064481 RYR1 0.480315 VCL 928
10 FKRP 15 MB 0.043576 SNTA1 0.469231 ILF2 736
Table 2. The crucial nodes considering a hub or bottleneck gene included in the selected nodes based on closeness and stress 
R Gene Name Description D B c s Disease score
1 DMD dystrophin 39 0.41 0.66 4516 4
2 UTRN utrophin 25 0.10 0.54 1890 2.66
3 TTN titin 19 0.07 0.53 - 1
4 DNM2 dynamin 2 9 0.19 0.48 2232 2.22
5 RYR1 ryanodine receptor 1 (skeletal) 12 0.10 0.48 1200 0.87
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Figure 2. The pie chart shows significant contributed biological processes related to the main 
network of the Becker muscular dystrophy. The most highlighted group here is the green part. 
The network statistical properties are as follow: P<0.05, Kappa Score=0.5. 
Discussion 
Topological examination implements remarkable properties of interaction basis of molecular 
concept of any kinds of diseases (21). Proteins with such characteristics are essential for network 
integrity and strength (22). In this study, proteins with such properties are suggested for BMD. In 
Figure 1, the first component of the network is a medium network that the most essential 
properties are contributing in this part. Other components are isolated or small communities not 
considered. No interactions between these nodes and the main network may be due to either 
undiscovered interactions or insignificant contribution of these proteins for BMD. The range of 
contribution of the isolated nodes to the disease is between 0.5-1 and for the other nodes is 
between 0.5-4 (Table 2). 
Figure 2. The pie chart shows significant contributed biological processes related to the main network of the Becker muscular dystrophy. The most 
highlighted group here is the green part. The network statistical properties are s follow: P<0.05, Kappa Score=0.5.
Discussion
Topological examination implements remarkable 
properties of interaction basis of molecular 
concept of any kinds of diseases (21). Proteins 
with such characteristics are essential for network 
integrity and strength (22). In this study, proteins 
with such properties are suggested for BMD. In 
Figure 1, the first component of the network is a 
medium network that the most essential properties 
are contributing in this part. Other components 
are isolated or small communities not considered. 
No interactions between these nodes and the 
main network may be due to either undiscovered 
interactions or insignificant contribution of these 
proteins for BMD. The range of contribution of the 
isolated nodes to the disease is between 0.5-1 and 
for the other nodes is between 0.5-4 (Table 2).
DMD has the highest score which is 4. Nodes within 
main network are more associated with BMD than 
the other ones to the disease. DMD plays a role as 
the core of the network. Furthermore, DMD is the 
highest scored in terms of degree and betweenness 
values, which is a top-rated hub and bottleneck node 
( ub-bottlen ck node). The ass ciation between 
this protein and BMD is strong as indic ted as 
disease score. By considering the five crucial genes, 
in fact, 8.5% of the nodes were considered as key 
proteins. These nodes include DMD, UTRN, TTN, 
DNM2, and RYR1. These proteins were again 
searched against literature and finally, the result 
showed that they are highly pertinent to BMD. In 
addition to high values of centrality parameters, 
the disease score values of these central nodes are 
is the highest compared to other nodes.
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Utrophin the other key protein is well known as a 
relevant protein to the two Duchenne and becker 
muscle dystrophies (23-25). Tight correlation 
between dystrophin and utrophin expression 
in Duchenne and becker patient is proved and 
discussed (26). Titin, the third key protein in the 
introduced possible biomarker panel is a giant 
sarcomeric filamentous polypeptide molecule. It is 
a component of striated muscle. There are evidence 
that titin plays a fundamental role in maintaining 
sarcomeric structural integrity. Responsibility 
for the passive elasticity of muscle is the main 
biological role of titin (27-29). 
The role of dynamin-2 (DNM2) in pathology of 
autosomal dominant centronuclear myopathy is 
investigated and reported by several researchers. 
This myopathy is usually a mild and clinically 
heterogeneous muscle disorder. Muscle weakness 
is the known characteristic of the patients. The 
nuclei are centralized in the biopsy of the patients 
(30-32).
Encoding isoform ryanodine receptor in the skeletal 
muscle by RYR1 gene is reported. This protein has 
a fundamental role in the excitation-contraction 
coupling process in the skeletal muscle. Control of 
calcium homeostasis by RyR1 is a significant role 
of this gene because intracellular calcium channel 
has a crucial role in muscle contraction (33, 34).
Centrality analysis indicates that while DMD has 
key properties in the network, other associated 
proteins may be fundamental in the BMD. 
Apparently, DMD is well-documented in Becker 
muscular dystrophy as well (35-37). Muscular 
dystrophy may trigger from malfunction of this 
protein. Role and centrality of this protein to be 
assessed also in other muscular dystrophies. 
Gene ontology analysis can express different 
properties of a group of proteins. The proteins 
contributing in a same network of BMD are 
inspected for biological process analysis. The 
biological process examination of BMD related 
proteins with different scores show that the 
Muscular Contraction is the most important 
biological process for BMD pathogenesis. Other 
processes are also important in this disease. 
Therefore, dysregulation of the assigned BMD 
proteins may lead to disruption of biological 
processes and mainly the highlighted one namely, 
Muscular Contraction. Muscle cell development 
and cardiac muscle tissue development are 
introduced as the second and the third important 
biological processes. As it is depicted in Figure 2, 
about 10 processes that tightly are related to the 
control of muscle function are listed.
In conclusion, DMD targeting may be the main 
concern for dystrophy clinical approaches. 
However, the presence of the other central 
proteins in the introduced panel also is confirmed 
by literature. Validity of this finding should be 
assessed via more complementary investigation. 
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